STOCK TITAN
  1. Home
  2. Sec-filings
  3. XRAY
  4. [Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity

DENTSPLY SIRONA Inc. (XRAY) director awarded 22,822 RSUs in new grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

VARON LESLIE F reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. director Leslie F. Varon received an equity grant of 22,822 shares in the form of Restricted Stock Units (RSUs). The RSUs vest in full one year from the grant date, meaning the restrictions lapse at that time.

After this award, Varon directly holds 80,364 shares of the company’s common stock, reflecting a routine, compensation-related increase in her ownership rather than an open-market purchase.

Positive

  • None.

Negative

  • None.
Insider VARON LESLIE F
Role null
Type Security Shares Price Value
Grant/Award Common Stock 22,822 $0.00 --
Holdings After Transaction: Common Stock — 80,364 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 22,822 units Restricted Stock Units vesting in full one year from grant
Grant price $0.00 per share Equity compensation, not an open-market purchase
Total shares after grant 80,364 shares Director’s direct common stock holdings following the RSU award
Transaction code A Grant, award, or other acquisition of non-derivative securities
Restricted Stock Units (RSUs) financial
"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full..."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Form 4 regulatory
"reported as an acquisition on a Form 4 insider filing"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
vest in full financial
"RSUs that vest in full (restrictions lapse) one year from date of grant"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
VARON LESLIE F
(Last)(First)(Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE
(Street)
CHARLOTTE NORTH CAROLINA 28277
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026A22,822(1)A$080,364D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Leslie F. Varon06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for Leslie Varon?

DENTSPLY SIRONA reported that director Leslie F. Varon received a grant of 22,822 Restricted Stock Units (RSUs). The award is compensation-related, not an open-market purchase, and was recorded as an acquisition on a Form 4 insider filing.

How many shares does Leslie Varon hold in DENTSPLY SIRONA (XRAY) after this grant?

Following the RSU grant, Leslie F. Varon directly holds 80,364 shares of DENTSPLY SIRONA common stock. This figure reflects her total direct ownership after adding the 22,822-share RSU award reported in the Form 4.

What are the vesting terms of Leslie Varon’s RSU grant at DENTSPLY SIRONA (XRAY)?

The grant consists entirely of Restricted Stock Units that vest in full one year from the date of grant. When vesting occurs, the restrictions lapse, and Varon will receive the underlying common shares, assuming continued satisfaction of the grant conditions.

Was Leslie Varon’s DENTSPLY SIRONA (XRAY) transaction a market purchase or sale?

The transaction was not a market purchase or sale; it was a grant of 22,822 RSUs at a price of $0.00 per unit. This reflects equity-based compensation awarded by the company rather than trading in the open market.

What does the Form 4 for DENTSPLY SIRONA (XRAY) indicate about derivative holdings?

The Form 4 shows no derivative transactions or remaining derivative positions for Leslie F. Varon in this filing. The reported activity relates solely to a non-derivative RSU-based equity grant tied to the company’s common stock.